Global Edaravone Market Report 2021 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2027 (Based on 2020 COVID-19 Worldwide Spread)
Global Edaravone Market Report 2021 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2027 (Based on 2020 COVID-19 Worldwide Spread)
The Edaravone study provides a comprehensive overview of safety standards, market penetration, and innovation pipelines across major economies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The Edaravone market is expected to grow from USD X.X million in 2021 to USD X.X million by 2027, at a CAGR of X.X% during the forecast period. The global Edaravone market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Edaravone market. The report focuses on well-known providers in the global Edaravone industry, market segments, competition, and the macro environment.
Under COVID-19 Outbreak, how the Edaravone Industry will develop is also analyzed in detail in Chapter 1.7 of the report.
In Chapter 2.4, we analyzed industry trends in the context of COVID-19.
In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.
In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.
In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.
A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.
Key players in the global Edaravone market covered in Chapter 4:
Unichem Laboratories Ltd
Mitsubishi Tanabe Pharma
UCB India Ltd
Piramal Healthcare
Taj Pharmaceuticals Ltd.
Simcere
Sun Pharmaceutical Industries Ltd.
In Chapter 11 and 13.3, on the basis of types, the Edaravone market from 2016 to 2027 is primarily split into:
Oral
Injection
In Chapter 12 and 13.4, on the basis of applications, the Edaravone market from 2016 to 2027 covers:
Hospital
Clinic
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2016-2027) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:
North America (Covered in Chapter 6 and 13)
United States
Canada
Mexico
Europe (Covered in Chapter 7 and 13)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8 and 13)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 9 and 13)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 10 and 13)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Period: 2021-2027
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Regulatory Scenario by Region/Country
1.4 Market Investment Scenario Strategic
1.5 Market Analysis by Type
1.5.1 Global Edaravone Market Share by Type (2021-2027)
1.5.2 Oral
1.5.3 Injection
1.6 Market by Application
1.6.1 Global Edaravone Market Share by Application (2021-2027)
1.6.2 Hospital
1.6.3 Clinic
1.6.4 Others
1.7 Edaravone Industry Development Trends under COVID-19 Outbreak
1.7.1 Global COVID-19 Status Overview
1.7.2 Influence of COVID-19 Outbreak on Edaravone Industry Development
2. Global Market Growth Trends
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
2.3 Industry News and Policies by Regions
2.3.1 Industry News
2.3.2 Industry Policies
2.4 Industry Trends Under COVID-19
3 Value Chain of Edaravone Market
3.1 Value Chain Status
3.2 Edaravone Manufacturing Cost Structure Analysis
3.2.1 Production Process Analysis
3.2.2 Manufacturing Cost Structure of Edaravone
3.2.3 Labor Cost of Edaravone
3.2.3.1 Labor Cost of Edaravone Under COVID-19
3.3 Sales and Marketing Model Analysis
3.4 Downstream Major Customer Analysis (by Region)
3.5 Value Chain Status Under COVID-19
4 Players Profiles
4.1 Unichem Laboratories Ltd
4.1.1 Unichem Laboratories Ltd Basic Information
4.1.2 Edaravone Product Profiles, Application and Specification
4.1.3 Unichem Laboratories Ltd Edaravone Market Performance (2016-2021)
4.1.4 Unichem Laboratories Ltd Business Overview
4.2 Mitsubishi Tanabe Pharma
4.2.1 Mitsubishi Tanabe Pharma Basic Information
4.2.2 Edaravone Product Profiles, Application and Specification
4.2.3 Mitsubishi Tanabe Pharma Edaravone Market Performance (2016-2021)
4.2.4 Mitsubishi Tanabe Pharma Business Overview
4.3 UCB India Ltd
4.3.1 UCB India Ltd Basic Information
4.3.2 Edaravone Product Profiles, Application and Specification
4.3.3 UCB India Ltd Edaravone Market Performance (2016-2021)
4.3.4 UCB India Ltd Business Overview
4.4 Piramal Healthcare
4.4.1 Piramal Healthcare Basic Information
4.4.2 Edaravone Product Profiles, Application and Specification
4.4.3 Piramal Healthcare Edaravone Market Performance (2016-2021)
4.4.4 Piramal Healthcare Business Overview
4.5 Taj Pharmaceuticals Ltd.
4.5.1 Taj Pharmaceuticals Ltd. Basic Information
4.5.2 Edaravone Product Profiles, Application and Specification
4.5.3 Taj Pharmaceuticals Ltd. Edaravone Market Performance (2016-2021)
4.5.4 Taj Pharmaceuticals Ltd. Business Overview
4.6 Simcere
4.6.1 Simcere Basic Information
4.6.2 Edaravone Product Profiles, Application and Specification
4.6.3 Simcere Edaravone Market Performance (2016-2021)
4.6.4 Simcere Business Overview
4.7 Sun Pharmaceutical Industries Ltd.
4.7.1 Sun Pharmaceutical Industries Ltd. Basic Information
4.7.2 Edaravone Product Profiles, Application and Specification
4.7.3 Sun Pharmaceutical Industries Ltd. Edaravone Market Performance (2016-2021)
4.7.4 Sun Pharmaceutical Industries Ltd. Business Overview
5 Global Edaravone Market Analysis by Regions
5.1 Global Edaravone Sales, Revenue and Market Share by Regions
5.1.1 Global Edaravone Sales by Regions (2016-2021)
5.1.2 Global Edaravone Revenue by Regions (2016-2021)
5.2 North America Edaravone Sales and Growth Rate (2016-2021)
5.3 Europe Edaravone Sales and Growth Rate (2016-2021)
5.4 Asia-Pacific Edaravone Sales and Growth Rate (2016-2021)
5.5 Middle East and Africa Edaravone Sales and Growth Rate (2016-2021)
5.6 South America Edaravone Sales and Growth Rate (2016-2021)
6 North America Edaravone Market Analysis by Countries
6.1 North America Edaravone Sales, Revenue and Market Share by Countries
6.1.1 North America Edaravone Sales by Countries (2016-2021)
6.1.2 North America Edaravone Revenue by Countries (2016-2021)
6.1.3 North America Edaravone Market Under COVID-19
6.2 United States Edaravone Sales and Growth Rate (2016-2021)
6.2.1 United States Edaravone Market Under COVID-19
6.3 Canada Edaravone Sales and Growth Rate (2016-2021)
6.4 Mexico Edaravone Sales and Growth Rate (2016-2021)
7 Europe Edaravone Market Analysis by Countries
7.1 Europe Edaravone Sales, Revenue and Market Share by Countries
7.1.1 Europe Edaravone Sales by Countries (2016-2021)
7.1.2 Europe Edaravone Revenue by Countries (2016-2021)
7.1.3 Europe Edaravone Market Under COVID-19
7.2 Germany Edaravone Sales and Growth Rate (2016-2021)
7.2.1 Germany Edaravone Market Under COVID-19
7.3 UK Edaravone Sales and Growth Rate (2016-2021)
7.3.1 UK Edaravone Market Under COVID-19
7.4 France Edaravone Sales and Growth Rate (2016-2021)
7.4.1 France Edaravone Market Under COVID-19
7.5 Italy Edaravone Sales and Growth Rate (2016-2021)
7.5.1 Italy Edaravone Market Under COVID-19
7.6 Spain Edaravone Sales and Growth Rate (2016-2021)
7.6.1 Spain Edaravone Market Under COVID-19
7.7 Russia Edaravone Sales and Growth Rate (2016-2021)
7.7.1 Russia Edaravone Market Under COVID-19
8 Asia-Pacific Edaravone Market Analysis by Countries
8.1 Asia-Pacific Edaravone Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Edaravone Sales by Countries (2016-2021)
8.1.2 Asia-Pacific Edaravone Revenue by Countries (2016-2021)
8.1.3 Asia-Pacific Edaravone Market Under COVID-19
8.2 China Edaravone Sales and Growth Rate (2016-2021)
8.2.1 China Edaravone Market Under COVID-19
8.3 Japan Edaravone Sales and Growth Rate (2016-2021)
8.3.1 Japan Edaravone Market Under COVID-19
8.4 South Korea Edaravone Sales and Growth Rate (2016-2021)
8.4.1 South Korea Edaravone Market Under COVID-19
8.5 Australia Edaravone Sales and Growth Rate (2016-2021)
8.6 India Edaravone Sales and Growth Rate (2016-2021)
8.6.1 India Edaravone Market Under COVID-19
8.7 Southeast Asia Edaravone Sales and Growth Rate (2016-2021)
8.7.1 Southeast Asia Edaravone Market Under COVID-19
9 Middle East and Africa Edaravone Market Analysis by Countries
9.1 Middle East and Africa Edaravone Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Edaravone Sales by Countries (2016-2021)
9.1.2 Middle East and Africa Edaravone Revenue by Countries (2016-2021)
9.1.3 Middle East and Africa Edaravone Market Under COVID-19
9.2 Saudi Arabia Edaravone Sales and Growth Rate (2016-2021)
9.3 UAE Edaravone Sales and Growth Rate (2016-2021)
9.4 Egypt Edaravone Sales and Growth Rate (2016-2021)
9.5 Nigeria Edaravone Sales and Growth Rate (2016-2021)
9.6 South Africa Edaravone Sales and Growth Rate (2016-2021)
10 South America Edaravone Market Analysis by Countries
10.1 South America Edaravone Sales, Revenue and Market Share by Countries
10.1.1 South America Edaravone Sales by Countries (2016-2021)
10.1.2 South America Edaravone Revenue by Countries (2016-2021)
10.1.3 South America Edaravone Market Under COVID-19
10.2 Brazil Edaravone Sales and Growth Rate (2016-2021)
10.2.1 Brazil Edaravone Market Under COVID-19
10.3 Argentina Edaravone Sales and Growth Rate (2016-2021)
10.4 Columbia Edaravone Sales and Growth Rate (2016-2021)
10.5 Chile Edaravone Sales and Growth Rate (2016-2021)
11 Global Edaravone Market Segment by Types
11.1 Global Edaravone Sales, Revenue and Market Share by Types (2016-2021)
11.1.1 Global Edaravone Sales and Market Share by Types (2016-2021)
11.1.2 Global Edaravone Revenue and Market Share by Types (2016-2021)
11.2 Oral Sales and Price (2016-2021)
11.3 Injection Sales and Price (2016-2021)
12 Global Edaravone Market Segment by Applications
12.1 Global Edaravone Sales, Revenue and Market Share by Applications (2016-2021)
12.1.1 Global Edaravone Sales and Market Share by Applications (2016-2021)
12.1.2 Global Edaravone Revenue and Market Share by Applications (2016-2021)
12.2 Hospital Sales, Revenue and Growth Rate (2016-2021)
12.3 Clinic Sales, Revenue and Growth Rate (2016-2021)
12.4 Others Sales, Revenue and Growth Rate (2016-2021)
13 Edaravone Market Forecast by Regions (2021-2027)
13.1 Global Edaravone Sales, Revenue and Growth Rate (2021-2027)
13.2 Edaravone Market Forecast by Regions (2021-2027)
13.2.1 North America Edaravone Market Forecast (2021-2027)
13.2.2 Europe Edaravone Market Forecast (2021-2027)
13.2.3 Asia-Pacific Edaravone Market Forecast (2021-2027)
13.2.4 Middle East and Africa Edaravone Market Forecast (2021-2027)
13.2.5 South America Edaravone Market Forecast (2021-2027)
13.3 Edaravone Market Forecast by Types (2021-2027)
13.4 Edaravone Market Forecast by Applications (2021-2027)
13.5 Edaravone Market Forecast Under COVID-19
14 Appendix
14.1 Methodology
14.2 Research Data Source
List of Tables and Figures
Table Global Edaravone Market Size Growth Rate by Type (2021-2027)
Figure Global Edaravone Market Share by Type in 2020 & 2026
Figure Oral Features
Figure Injection Features
Table Global Edaravone Market Size Growth by Application (2021-2027)
Figure Global Edaravone Market Share by Application in 2020 & 2026
Figure Hospital Description
Figure Clinic Description
Figure Others Description
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Edaravone Industry Development
Table SWOT Analysis
Figure Porter's Five Forces Analysis
Figure Global Edaravone Market Size and Growth Rate 2016-2027
Table Industry News
Table Industry Policies
Figure Value Chain Status of Edaravone
Figure Production Process of Edaravone
Figure Manufacturing Cost Structure of Edaravone
Figure Major Company Analysis (by Business Distribution Base, by Product Type)
Table Downstream Major Customer Analysis (by Region)
Table Unichem Laboratories Ltd Profile
Table Unichem Laboratories Ltd Production, Value, Price, Gross Margin 2016-2021
Table Mitsubishi Tanabe Pharma Profile
Table Mitsubishi Tanabe Pharma Production, Value, Price, Gross Margin 2016-2021
Table UCB India Ltd Profile
Table UCB India Ltd Production, Value, Price, Gross Margin 2016-2021
Table Piramal Healthcare Profile
Table Piramal Healthcare Production, Value, Price, Gross Margin 2016-2021
Table Taj Pharmaceuticals Ltd. Profile
Table Taj Pharmaceuticals Ltd. Production, Value, Price, Gross Margin 2016-2021
Table Simcere Profile
Table Simcere Production, Value, Price, Gross Margin 2016-2021
Table Sun Pharmaceutical Industries Ltd. Profile
Table Sun Pharmaceutical Industries Ltd. Production, Value, Price, Gross Margin 2016-2021
Figure Global Edaravone Sales and Growth Rate (2016-2021)
Figure Global Edaravone Revenue ($) and Growth (2016-2021)
Table Global Edaravone Sales by Regions (2016-2021)
Table Global Edaravone Sales Market Share by Regions (2016-2021)
Table Global Edaravone Revenue ($) by Regions (2016-2021)
Table Global Edaravone Revenue Market Share by Regions (2016-2021)
Table Global Edaravone Revenue Market Share by Regions in 2016
Table Global Edaravone Revenue Market Share by Regions in 2020
Figure North America Edaravone Sales and Growth Rate (2016-2021)
Figure Europe Edaravone Sales and Growth Rate (2016-2021)
Figure Asia-Pacific Edaravone Sales and Growth Rate (2016-2021)
Figure Middle East and Africa Edaravone Sales and Growth Rate (2016-2021)
Figure South America Edaravone Sales and Growth Rate (2016-2021)
Figure North America Edaravone Revenue ($) and Growth (2016-2021)
Table North America Edaravone Sales by Countries (2016-2021)
Table North America Edaravone Sales Market Share by Countries (2016-2021)
Figure North America Edaravone Sales Market Share by Countries in 2016
Figure United States Edaravone Sales and Growth Rate (2016-2021)
Figure Canada Edaravone Sales and Growth Rate (2016-2021)
Figure Mexico Edaravone Sales and Growth (2016-2021)
Figure Europe Edaravone Revenue ($) Growth (2016-2021)
Table Europe Edaravone Sales by Countries (2016-2021)
Table Europe Edaravone Sales Market Share by Countries (2016-2021)
Figure Germany Edaravone Sales and Growth Rate (2016-2021)
Figure UK Edaravone Sales and Growth Rate (2016-2021)
Figure France Edaravone Sales and Growth Rate (2016-2021)
Figure Italy Edaravone Sales and Growth Rate (2016-2021)
Figure Spain Edaravone Sales and Growth Rate (2016-2021)
Figure Russia Edaravone Sales and Growth Rate (2016-2021)
Figure Asia-Pacific Edaravone Revenue ($) and Growth (2016-2021)
Table Asia-Pacific Edaravone Sales by Countries (2016-2021)
Table Asia-Pacific Edaravone Sales Market Share by Countries (2016-2021)
Figure China Edaravone Sales and Growth Rate (2016-2021)
Figure Japan Edaravone Sales and Growth Rate (2016-2021)
Figure South Korea Edaravone Sales and Growth Rate (2016-2021)
Figure Australia Edaravone Sales and Growth Rate (2016-2021)
Figure India Edaravone Sales and Growth Rate (2016-2021)
Figure Southeast Asia Edaravone Sales and Growth Rate (2016-2021)
Figure Middle East and Africa Edaravone Revenue ($) and Growth (2016-2021)
Table Middle East and Africa Edaravone Sales by Countries (2016-2021)
Table Middle East and Africa Edaravone Sales Market Share by Countries (2016-2021)
Figure Saudi Arabia Edaravone Sales and Growth Rate (2016-2021)
Figure UAE Edaravone Sales and Growth Rate (2016-2021)
Figure Egypt Edaravone Sales and Growth Rate (2016-2021)
Figure Nigeria Edaravone Sales and Growth Rate (2016-2021)
Figure South Africa Edaravone Sales and Growth Rate (2016-2021)
Figure South America Edaravone Revenue ($) and Growth (2016-2021)
Figure Brazil Edaravone Sales and Growth Rate (2016-2021)
Figure Argentina Edaravone Sales and Growth Rate (2016-2021)
Figure Columbia Edaravone Sales and Growth Rate (2016-2021)
Figure Chile Edaravone Sales and Growth Rate (2016-2021)
Table Global Edaravone Sales by Types (2016-2021)
Table Global Edaravone Revenue ($) by Types (2016-2021)
Figure Global Oral Sales and Growth Rate (2016-2021)
Figure Global Oral Price (2016-2021)
Figure Global Injection Sales and Growth Rate (2016-2021)
Figure Global Injection Price (2016-2021)
Table Global Edaravone Sales by Applications (2016-2021)
Table Global Edaravone Sales Share by Applications (2016-2021)
Figure Global Hospital Sales and Growth Rate (2016-2021)
Figure Global Hospital Revenue and Growth Rate (2016-2021)
Figure Global Clinic Sales and Growth Rate (2016-2021)
Figure Global Clinic Revenue and Growth Rate (2016-2021)
Figure Global Others Sales and Growth Rate (2016-2021)
Figure Global Others Revenue and Growth Rate (2016-2021)
Figure Global Edaravone Sales and Growth Rate (2021-2027)
Figure Global Edaravone Revenue ($) and Growth Rate (2021-2027)
Table Global Edaravone Sales Forecast by Regions (2021-2027)
Table Global Edaravone Revenue Forecast by Regions (2021-2027)
Figure North America Edaravone Sales Forecast (2021-2027)
Figure North America Edaravone Revenue Forecast (2021-2027)
Figure Europe Edaravone Sales Forecast (2021-2027)
Figure Europe Edaravone Revenue Forecast (2021-2027)
Figure Asia-Pacific Edaravone Sales Forecast (2021-2027)
Figure Asia-Pacific Edaravone Revenue Forecast (2021-2027)
Figure Middle East and Africa Edaravone Sales Forecast (2021-2027)
Figure Middle East and Africa Edaravone Revenue Forecast (2021-2027)
Figure South America Edaravone Sales Forecast (2021-2027)
Figure South America Edaravone Revenue Forecast (2021-2027)
Table Global Edaravone Sales Forecast by Types (2021-2027)
Table Global Edaravone Sales Market Share Forecast by Types (2021-2027)
Table Global Edaravone Revenue Market Share Forecast by Types (2021-2027)
Table Global Edaravone Sales Market Share Forecast by Applications (2021-2027)
Table Global Edaravone Revenue Forecast by Applications (2021-2027)
Table Global Edaravone Revenue Market Share Forecast by Applications (2021-2027)
Research Methodology:
Edaravone Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|